FDA Inspection 1199359 — TOLMAR, Inc.
The FDA completed an inspection of TOLMAR, Inc. on January 31, 2023 in Windsor, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 31, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Windsor, CO (United States)